Genomic Vision Société Anonyme announced revenue results for the third quarter and nine months of 2022. For the third quarter, the company reported total revenue from sales of EUR 257,000 compared to EUR 153,000 a year ago. Total revenue from activity was EUR 373,000 compared to EUR 234,000 a year ago.

For the nine months, the company reported total revenue from sales of EUR 768,000 compared to EUR 620,000 a year ago. Total revenue from activity was EUR 1,116,000 compared to EUR 940,000 a year ago.